Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Study of Congenital Pulmonic Valve Dysfunction Studying the SAPIEN 3 THV With the Alterra Adaptive Prestent

NCT03130777 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT03130777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03130777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Study of Congenital Pulmonic Valve Dysfunction Studying the SAPIEN 3 THV With the Alterra Adaptive Prestent
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 22, 2017
Completion date
June 30, 2032
Enrollment
86 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease, pulmonary disease, pulmonary regurgitation, tetralogy of fallot, transcatheter pulmonary valve replacement (tpvr)